Understanding the mechanisms of epigenetic remodeling that follow fertilization is a fundamental step toward understanding the bases of early embryonic development and pluripotency. Extensive and dynamic chromatin remodeling is observed after fertilization, including DNA methylation and histone modifications. These changes underlie the transition from gametic to embryonic chromatin and are thought to facilitate embryonic genome activation. In particular, trimethylation of histone 3 lysine 27 (H3K27me3) is associated with gene-specific transcription repression. Global levels of this epigenetic mark are high in oocyte chromatin and decrease to minimal levels at the time of embryonic genome activation. We provide evidence that the decrease in H3K27me3 observed during early development is cell-cycle independent, suggesting an active mechanism for removal of this epigenetic mark. Among H3K27me3-specific demethylases, Jumonji domain-containing protein 3 (JMJD3), but not ubiquitously transcribed tetratricopeptide repeat X (UTX), present high transcript levels in oocytes. Soon after fertilization JMJD3 protein levels increase, concurrent with a decrease in mRNA levels. This pattern of expression suggests maternal inheritance of JMJD3. Knockdown of JMJD3 by siRNA injection in parthenogenetically activated metaphase II oocytes resulted in inhibition of the H3K27me3 decrease normally observed in preimplantation embryos. Moreover, knockdown of JMJD3 in oocytes reduced the rate of blastocyst development. Overall, these results indicate that JMJD3 is involved in active demethylation of H3K27me3 during early embryo development and that this mark plays an important role during the progression of embryos to blastocysts. G amete nuclei undergo extensive chromatin remodeling soon after fertilization, including alterations to DNA methylation levels and posttranslational histone tail modification. These changes are known to influence chromatin structure and transcriptional readout (1) and also to promote embryonic genome activation (EGA) (2), which occurs in humans and cows after three to four cell divisions (3-5). Because the first few cell divisions occur without embryonic gene transcription, maternally inherited mRNA and proteins present in the oocyte are likely responsible for inducing these epigenetic changes (6).
Understanding the mechanisms of epigenetic remodeling that follow fertilization is a fundamental step toward understanding the bases of early embryonic development and pluripotency. Extensive and dynamic chromatin remodeling is observed after fertilization, including DNA methylation and histone modifications. These changes underlie the transition from gametic to embryonic chromatin and are thought to facilitate embryonic genome activation. In particular, trimethylation of histone 3 lysine 27 (H3K27me3) is associated with gene-specific transcription repression. Global levels of this epigenetic mark are high in oocyte chromatin and decrease to minimal levels at the time of embryonic genome activation. We provide evidence that the decrease in H3K27me3 observed during early development is cell-cycle independent, suggesting an active mechanism for removal of this epigenetic mark. Among H3K27me3-specific demethylases, Jumonji domain-containing protein 3 (JMJD3), but not ubiquitously transcribed tetratricopeptide repeat X (UTX), present high transcript levels in oocytes. Soon after fertilization JMJD3 protein levels increase, concurrent with a decrease in mRNA levels. This pattern of expression suggests maternal inheritance of JMJD3. Knockdown of JMJD3 by siRNA injection in parthenogenetically activated metaphase II oocytes resulted in inhibition of the H3K27me3 decrease normally observed in preimplantation embryos. Moreover, knockdown of JMJD3 in oocytes reduced the rate of blastocyst development. Overall, these results indicate that JMJD3 is involved in active demethylation of H3K27me3 during early embryo development and that this mark plays an important role during the progression of embryos to blastocysts. G amete nuclei undergo extensive chromatin remodeling soon after fertilization, including alterations to DNA methylation levels and posttranslational histone tail modification. These changes are known to influence chromatin structure and transcriptional readout (1) and also to promote embryonic genome activation (EGA) (2) , which occurs in humans and cows after three to four cell divisions (3) (4) (5) . Because the first few cell divisions occur without embryonic gene transcription, maternally inherited mRNA and proteins present in the oocyte are likely responsible for inducing these epigenetic changes (6) .
Histone lysine methylation is involved in transcriptional repression and/or activation and plays a key role during lineage specification and cell differentiation (7) . Di-and trimethylation of histone 3 lysine 27 (H3K27) are catalyzed by the polycomb repressive complex 2 (PRC2), which has three essential components: enhancer of zeste homolog 2 (EZH2), embryonic ectoderm development (EED), and suppressor of zeste 12 (SUZ12) (8) (9) (10) . These epigenetic marks are specifically associated with gene repression (11) and are typical of many key developmental genes in embryonic stem cells, stem cell maintenance (12) (13) (14) , and regulation of pluripotency (15) . In mouse embryos, asymmetric distribution of trimethylated H3K27 (H3K27me3) in the inner cell mass and trophectoderm has been related to lineage specification of embryonic and extraembryonic tissues (16, 17) ; however its role during EGA has not been determined. Studies in pig (18, 19) and cow (20) have shown a clear decrease of H3K27me3 level at the time of EGA, and different mechanisms responsible for this methylation loss have been suggested: (i) passive loss of methylation during DNA replication; (ii) active enzymatic removal of methylated marks; and (iii) a combination of these two mechanisms (20) .
Histone methylation was considered an irreversible process until the lysine-specific demethylase 1 was discovered in 2004 (21) (22) (23) . Later, Jumonji domain-containing (JMJD) proteins with demethylase activity at H3K27 residues were reported (24) (25) (26) (27) (28) (29) (30) , including ubiquitously transcribed tetratricopeptide repeat X (UTX) and JMJD3 (also known as "KDM6B"). UTX is ubiquitously expressed (31) , is required for proper activation of HOX genes and establishment of anterior-posterior identity (24, 25, 32) , and is involved in myogenesis (33) . JMJD3 is expressed predominantly in stem cells and is involved in differentiation and dedifferentiation processes including neural and epidermal differentiation, skin repair, and inflammation (11) . In mouse embryonic stem cells, JMJD3 participates in the Nodal and Brachyury pathways, both of which are critical during vertebrate development (34) .
The role of H3K27me3-specific demethylases during early embryo development has not been established. We hypothesized that JMJD3 and/or UTX are responsible for the global decrease in H3K27me3 observed after fertilization, facilitating EGA and enabling progression of embryonic development. To address this hypothesis, we first analyzed expression patterns of JMJD3 and UTX mRNA and JMJD3 protein during oocyte maturation and preimplantation development. We then studied the consequences of JMJD3 knockdown on H3K27me3 and developmental potential of the embryos. Our results show that JMJD3 mRNA provided by the oocyte is translated into protein before EGA and that its activity is required for active removal of H3K27me3 marks. Down-regulation of JMJD3 negatively impacted blastocyst development and total cell number in bovine embryos.
Results
Evidence for Active Removal of H3K27me3 During Preimplantation Development. We have shown previously that H3K27me3 levels decrease during the early stages of preimplantation embryo development to reach a nadir at the time of embryonic genome activation (35) . To determine whether the observed decrease in H3K27me3 levels during early cleavage divisions is an active or passive mechanism, we incubated bovine two-cell embryos in the presence of aphidicolin-a reversible DNA replication inhibitor that blocks the progression of cleavage divisions-and analyzed Author contributions: S.C., J.B.C., and P.J.R. designed research; S.C. and P.J.R. performed research; S.C. and P.J.R. analyzed data; and S.C., J.B.C., and P.J.R. wrote the paper.
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This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1119112109/-/DCSupplemental. the levels of H3K27me3 by semiquantitative determination of H3K27me3 immunofluorescence intensity (Fig. 1) . After the inhibitor was removed, a high proportion of embryos progressed to the four-cell stage, allowing us to compare the levels of H3K27me3 in embryos that had undergone subsequent cell divisions during the same amount of time.
Global levels of H3K27me3 decreased from two-cell to fourcell stages in control embryos. In embryos treated with aphidicolin (aphidicolin+) and thus blocked at the two-cell stage [2c, 46 h postactivation (hpa)], the levels of H3K27me3 were similar to those of control four-cell embryos (4c, 46 hpa, aphidicolin−) (Fig. 1B) . This result indicates that H3K27me3 levels had decreased in the absence of DNA replication. Moreover, differences were not observed at 56 hpa between treated (4-c, aphidicolin+) and nontreated (8-c, aphidicolin−) groups, even though the embryos had undergone different numbers of cells divisions. Together, these results suggest that the observed decrease in H3K27 methylation levels before EGA is the consequence of a cell division-independent mechanism.
H3K27me3 Demethylases JMJD3 and UTX mRNA Abundance During Oocyte Maturation and Preimplantation Development. Because enzymatic removal of methylated marks is a potential mechanism for the decrease in H3K27me3 levels, we characterized the mRNA abundance of JMJD3 and UTX (both histone demethylases with specific activity against H3K27me3) in bovine oocytes and in vitro-fertilized bovine embryos using real-time RT-PCR. UTX transcripts were detected only after EGA, at the morula and blastocysts stages ( Fig. 2A) . JMJD3 transcripts showed high expression levels in germinal vesicle (GV) and metaphase II (MII) oocytes, decreasing during the embryo cleavage stages to increase again at the blastocyst stage ( Fig. 2A) . Considering that deadenylation of transcripts is a common mechanism of mRNA storage in oocytes, we evaluated both levels of total transcripts and levels of polyadenylated transcript by performing the reverse-transcription reaction with random hexamer primers and oligo-dT, respectively. No differences were observed in the patterns of transcript abundance between the total and polyadenylated fractions (Fig. S1 ), indicating that deadenylation of transcripts may not be a major mechanism of posttranscriptional regulation for these genes. These results indicate that JMJD3, but not UTX, is expressed concurrent to the global decrease in H3K27me3 levels, suggesting that it may be involved in the modification of this epigenetic mark.
Expression and Localization of JMJD3 Protein in Preimplantation
Embryos. To determine the presence of JMJD3 protein in oocytes and preimplantation embryos, we performed immunoblot analysis using a commercial antibody raised against human JMJD3 on bovine oocytes and preimplantation embryos. A reactive band with the expected molecular weight (∼185 kDa) was detectable in two-and four-cell embryos but not in GV and MII oocytes (Fig. 2C) . We also observed a similar molecular-weight band in samples with two-cell and eight-to 16-cell stage embryos. Preincubating the antibody with a JMJD3 peptide resulted in the disappearance of the high-molecular-weight band, but other smaller, nonspecific bands remained (Fig. 2D ). This result confirms that the band detected at 185 kDa corresponds to JMJD3 and indicates that JMJD3 protein is present in bovine preimplantation embryos but not, at least in high levels, in oocytes. Immunofluorescence analysis using a custom rabbit polyclonal antibody against JMJD3 (27) in bovine oocytes and in vitroproduced embryos indicated that JMJD3 is localized to the nuclear compartment of preimplantation embryos, starting expression at the pronuclear stage (Fig. 2E ). Importantly, JMJD3 was not detected in GV and MII oocytes, confirming the Western blot results. Our results showed that JMJD3 is translated to protein soon after fertilization and persists, with oscillations, until the blastocyst stage. This expression pattern corresponds in time and cellular location with the decrease of H3K27me3 in preimplantation embryos (36) .
Role of JMJD3 in Histone Demethylation During Preimplantation
Development. To investigate the function of JMJD3 during preimplantation development, we designed and constructed siRNA species targeting JMJD3. The computationally predicted bovine JMJD3 transcript consists of 6,473 bp (Fig. 3A) . The putative gene is composed of 20 exons with an exon/intron distribution similar to the human JMJD3 gene. Two siRNA species were selected that targeted widely separated regions of the gene (Fig.  3A) , with their target sites located at 1077-1098 bp (JMJD3-1077 siRNA) and 5979-5900 bp (JMJD3-5979 siRNA) downstream from the start codon. A third siRNA without any specificity against JMJD3 or any other gene in the genome was used as a control.
To validate the efficacy and specificity of JMJD3 siRNAs, we microinjected them into MII oocytes and induced parthenogenetic activation (Fig. 3B) . Forty-eight hours after injection, we collected four-cell embryos and analyzed mRNA abundance of JMJD3 and four different control genes [β-actin (ACTB), ribosomal protein S18 (RPS18), ribosomal protein L15 (RPL15), and GAPDH]. Both siRNA species reduced JMJD3 mRNA levels by more than 90% (Fig. 3C) , whereas the abundance of the control genes was not altered (Fig. S2) . Immunofluorescence with methylated histone-specific antibodies was used to investigate the role of JMJD3 on H3K27me3 demethylation during preimplantation embryonic development. Embryos injected with JMJD3 siRNA and collected at the four-and eight-cell stages showed higher global levels of H3K27me3 than embryos injected with control siRNA, whereas global levels of H3K9me3 in fourcell embryos were unaltered (Fig. 3D ). This result indicates that JMJD3 is an H3K27me3-specific demethylase active in bovine preimplantation embryos and is responsible for the reported decrease in H3K27me3 that coincides with EGA in bovine embryos.
Effect of JMJD3 Knockdown on Parthenogenetic Embryo Development. Injection of JMJD3 siRNA in MII oocytes did not affect the proportion of embryos that cleaved after parthenogenetic activation (Fig. 4A) . On the other hand, the proportion of parthenogenetic embryos that developed to the blastocyst stage was lower (P < 0.05) in JMJD3 siRNA-injected groups (10 and 14%) than in control siRNA-injected (23%) and noninjected controls (27%) (Fig. 4B) . Furthermore, there was a tendency for blastocysts derived from JMJD3 siRNA-injected groups to have a lower total cell number than blastocysts from the control groups (78 and 82 vs. 99 and 102 cells per embryo, respectively; P < 0.1; Fig. 4C ). In embryos that reached the blastocyst stage, the relative level of JMJD3 mRNA was reduced in JMJD3 siRNA-treated embryos compared with controls, and this reduction was 40% relative to the siRNA control (Fig. 4D) . In this case, the level of JMJD3 was quantified relative to RPS18, a gene not affected by JMJD3 siRNA injection, to account for the differences in cell number between treatment and control blastocysts. These results show that JMJD3 knockdown reduced the developmental capacity of parthenogenetic embryos. Furthermore, siRNA injection in MII oocytes reduced the level of JMJD3 mRNA at blastocyst stage and resulted in decreased blastocyst cell numbers.
Discussion
Histone modifications are mechanisms of epigenetic control that are just beginning to be understood (37) . H3K27me3, in particular, is associated with gene repression, although certain genes can be expressed despite H3K27me3 promoter occupancy (37) . This epigenetic state is known to be involved in the regulation of key developmental genes in embryonic stem cells (12) (13) (14) and is involved in regulation of pluripotency (15) . The decrease in H3K27me3 levels in preimplantation embryos was reported previously in different species (16, (18) (19) (20) , but the mechanism responsible for this decrease was unknown. In this study we hypothesized that maternally inherited H3K27me3-specific demethylases (such as JMJD3 and/or UTX) participate in the decreases of this mark before EGA and that they facilitate EGA, enabling progression of embryonic development. A potential mechanism to explain the decrease in H3K27me3 observed during embryonic cleavage divisions is the dilution of methylated marks following cell division, during incorporation of new histones in the absence of PCR2 complex activity (16, 19, 20) . To differentiate between cell division-dependent and -independent H3K27me3 demethylation mechanisms, we reversibly blocked cell-cycle progression in early embryos and analyzed H3K27me3 levels. Moreover, because H3K27me3 is detectable only on maternally derived chromatin (16, 19, 20) , we used parthenogenetic embryos. These embryos have the advantage that any observed decrease on H3K27me3 is not confounded by the incorporation of unmodified histones during replacement of sperm protamines. Moreover, parthenogenetic embryos undergo H3K27me3 alterations similar to those seen in fertilized oocytes and develop to the blastocyst stage at similar rates (Fig. S3) .
Results indicated that the decrease in H3K27me3 levels does not require cell division, ruling out the possibility that this mark decreases passively by dilution during DNA replication and giving credence to the notion that an active enzymatic mechanism may be responsible for removal of this mark. Enzymes responsible for posttranslational modifications of histone proteins play important roles in a wide range of biological processes that require stable changes in gene expression (e.g., cellular differentiation) (38) . In early embryos, histone deacetylase (39) and H3K9 demethylase (JMJD2C) (40) are known to be important for embryo development. Indirect evidence also suggests the existence of other histone demethylases which could act on H3K27 and H3K9 methylation marks in preimplantation embryos (18, 19) .
JMJD3 and UTX are enzymes with specific demethylation activity on H3K27me3 residues (24, 28) . In oocytes and preimplantation embryos we detected UTX transcripts only after EGA, in accordance with a previous report in pigs (18) , ruling out the possibility that UTX is involved in H3K27me3 decrease during pre-EGA development. In contrast, JMJD3 was highly expressed in bovine GV and MII oocytes, as observed in our reported transcriptome of human MII oocytes (41) . After fertilization, JMJD3 mRNA levels decreased significantly. This decrease could be the result of mRNA degradation, protein synthesis, or both. Deadenylation and readenylation were discarded as potential mechanisms for regulation of JMJD3 function during these stages of development by comparing expression levels from random hexamer-and oligo-dT-primed cDNA. In post-EGA stages, JMJD3 mRNA and UTX transcript levels increased as a result of transcription from the embryonic genome; this result is in accordance with the published data in pigs (18) .
High levels of JMJD3 and UTX transcripts in blastocysts are indicative of high chromatin remodeling activity at this stage of development. Also, the increase in transcript levels coincided with increased global levels of H3K27me3 (20) , suggesting that at this stage the activity of JMJD3 and UTX may be directed toward loci-specific sites instead of inducing global H3K27me3 demethylation.
The detection of JMJD3 protein only after fertilization indicates that JMJD3 mRNA is stored by the oocyte during the pre-EGA stages and is translated after fertilization. Given the role of JMJD3, it would be interesting to know if the level of JMJD3 mRNA stored in the ooplasm is linked to the quality or developmental potential of embryos, as has been described previously for other maternally derived transcripts (42) , and if maturation processes (in vivo or in vitro) or other factors (age, environmental contaminants) could affect the storage of these transcripts.
JMJD3 protein was found throughout early embryonic development and localized to the nuclei of embryonic blastomeres, a finding compatible in time and location with its proposed role in the reduction of H3K27me3 levels observed before EGA. To dissect JMJD3 functions in zygotes, we used an RNAi-based approach (43, 44) . We took into consideration recommendations regarding size and complementarity of experimental controls to achieve siRNA target specificity (45, 46) . Depletion of oocyte mRNA should result in a functional knockdown of JMJD3 activity, assuming that JMJD3 is not translated until after fertilization. Injection of siRNA was performed in denuded MII oocytes and in oocytes activated by parthenogenesis. Parthenogenetic embryos undergo changes in H3K27me3 similar to those in fertilized oocytes and develop to the blastocyst stage at similar rates (Fig. S3) . The efficiency and specificity of JMJD3 siRNA species was validated by analysis of JMJD3 (target) and housekeeping gene mRNA abundance. Moreover, injection of JMJD3 siRNA effectively blocked the decrease in H3K27me3 levels normally observed in four-and eight-cell embryos but had no effect on another epigenetic mark, H3K9me3. These results support the idea that maternally provided JMJD3 present in the oocyte as mRNA is responsible for the global decrease in H3K27me3 observed during early development (pre-EGA).
RNAi-mediated ablation of JMJD3 also affected embryo development to the blastocyst stage. No effects were observed on embryo cleavage rate, suggesting that in bovine embryos JMJD3 activity is not required for the initial cell divisions. We propose that removal of H3K27me3 mediated by JMJD3 activity is required to facilitate activation of the embryonic genome and that persistence of these marks at the eight-to 16-cell stage impairs further embryonic development. Little is known about how JMJD3 is linked to pathways that control early development. Studies in mouse embryonic stem cells have shown that Nodal signaling activates SMAD family member 2 and member 3, which then recruit JMJD3 and lead to loss of H3K27me3, dissociation of PRC2 components, and ultimately to the expression of target genes (34) . Recent work by two independent groups has demonstrated that JMJD3-KO mice can develop but are stillborn or die shortly after birth (47, 48) . This in vivo evidence would seem to argue against our findings (i.e., developmental blockage of preimplantation embryos). However, KO mouse embryos were generated from crosses between heterozygous KO mice, and therefore maternal JMJD3 mRNA is likely to aid mouse preimplantation embryos during the early stages of development. Because homozygous JMJD3-KO female mice cannot be obtained because of perinatal mortality, testing the role of maternal JMJD3 in early mouse embryonic development likely will involve the generation of conditional JMJD3 KO expressed only in growing oocytes.
Further questions regarding JMJD3 functions during embryo development are (i) whether JMJD3 also could be involved in removal of this epigenetic mark (H3K27me3) in long-noncoding (lnc) RNAs, and (ii) whether JMJD3 plays a demethylase-independent role during embryo development. EZH2-mediated H3K27 methylation plays an important role in silencing lncRNAs in embryonic stem cells, suggesting that lncRNAs are epigenetically regulated in a manner similar to protein-coding genes (49) and that JMJD3 also could be involved in removing this repressive mark in lncRNAs. A demethylase-independent role of JMJD3 has been described in differentiated cells (T-helper 1 cells) in which the epigenetic profile is already established and fulfills another role. Specifically, JMJD3 mediates a functional interaction between T-bet, a T-box transcription factor, and a Brg1-containing switch/sucrose nonfermentable (SWI/SNF) remodeling complex (50) . We have confirmed that JMJD3 acts during the active demethylation process of early embryo development, but we are not able to rule out the possibility that JMJD3 also enacts demethylase-independent consequences during embryo development. Future studies should be aimed at addressing these questions.
In summary, our results show that H3K27me3 levels undergo active removal of methyl groups during preimplantation development and strongly indicate that JMJD3 is responsible for the regulation of H3K27me3 during early embryo development. JMJD3, but not UTX, expression was detected and translated to protein soon after fertilization and before EGA, indicating a maternal source of JMJD3. Protein nuclear localization of JMJD3 at the same time shows that a global decrease in H3K27me3 levels occurs, further suggesting its association in this process. RNAimediated knockdown of JMJD3 confirmed such a possibility, resulting in a lack of decrease in H3K27me3 levels in four-and eight-cell embryos. Moreover, depletion of JMJD3 mRNA resulted in lower developmental capacity in parthenogenetic embryos. In conclusion, our study describes the role of an H3K27me3 demethylase, JMJD3, in early embryo development and suggests that maternal transcripts of this gene play a critical role during embryo genome activation and blastocyst development.
Materials and Methods
Embryos were produced by parthenogenetic activation or in vitro fertilization. In experiment 1, parthenogenetic embryos were treated with aphidicolin (a reversible DNA replication inhibitor that blocks the progression of cleavage divisions) for 12 h, and H3K27me3 levels were measured at 32, 46, and 56 h postactivation. For gene expression analysis, total RNA was collected from GV, MII, pronuclear (PN), two-, four-, eight-, 16-cell-, morula-, and blastocyst-stage embryos produced by in vitro fertilization. Total and polyadenylated JMJD3 mRNA levels were determined by quantitative real-time PCR. The presence of JMJD3 protein was analyzed using Western blot in GV, MII, two-cell and eightto 16-cell-stage embryos. Two different siRNA species were designed and produced using the Silencer siRNA construction kit (Ambion). MII oocytes were injected with ∼6 pL of 25 μM JMJD3-5979, JMJD3-1077, or control (nonspecific) siRNA, followed by parthenogenetic activation. Embryos were cultured in vitro for 7 d. Four-cell-and blastocyst-stage embryos were collected to determine the levels of JMJD3, GADPH, ACTB, RPS18, and RPL15 mRNA by quantitative real-time PCR. Also, two-, four-, eight-and 16-cell embryos were fixed and stained with H3K27me3 and H3K9me3 antibodies to analyze fluorescence levels for these marks. Cleavage rate, blastocyst formation rate, and blastocyst cell number were analyzed in all groups. Further details are provided in SI Materials and Methods.
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